A preoperative test that is sensitive and specific for endometrial cancer and correlated with risk factors with nodal metastasis in early disease could be useful in identifying cases that would benefit from lymphadenectomy and excluding those that would not MRI tumor markers (CA125– HE4) are non-invasive diagnostic methods for preoperative staging of endometrial cancer. This evidence concerns the gene WFDC2 and neoplasm.